PM
PARRISH MARK W
Director
BoardM
Insider track record
Board DirectorAcross 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by PARRISH MARK W, Director. Officer active across 3 companies, notably OMNICELL, Inc. Cumulatively, 22 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €538k. History available since 25 May 2021. The latest transaction was filed on 4 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations22 total
18,204 shares0Common StockSEC:0000950170-25-034008:0
12,000 shares@ US$47.303274.2% of flowCommon StockSEC:0001415889-24-029080:0
6,143 shares0Common StockSEC:0001415889-24-014262:0
17,970 shares0Common StockSEC:0000950170-24-026651:0
115 shares0Common StockSEC:0001415889-23-012226:0
2,710 shares0Common StockSEC:0001415889-23-008791:0
19,608 shares0Common StockSEC:0000899243-23-007216:0
3,000 shares@ US$14.875.8% of flowCommon StockSEC:0001415889-22-013063:0
3,000 shares@ US$14.875.8% of flowCommon StockSEC:0001415889-22-012953:0
3,000 shares@ US$14.875.8% of flowCommon StockSEC:0001415889-22-012721:0
3,000 shares@ US$14.875.9% of flowCommon StockSEC:0001415889-22-012335:0
1,278 shares@ US$14.872.5% of flowCommon StockSEC:0001415889-22-011885:0
1,623 shares0Common StockSEC:0001415889-22-005694:0
2,000 shares@ US$14.870.0014% mcap22.7% of flowCommon StockSEC:0001179110-22-002639:0
2,000 shares@ US$14.870.0014% mcap22.4% of flowCommon StockSEC:0001179110-22-002420:0
166 shares0Common StockSEC:0000899243-22-011986:0
2,000 shares@ US$14.870.0014% mcap22.3% of flowCommon StockSEC:0001179110-22-002153:0
13,996 shares0Common StockSEC:0000899243-22-009555:0
3,000 shares@ US$14.870.0020% mcap32.6% of flowCommon StockSEC:0001179110-22-001527:0
3,000 shares0Common StockSEC:0001179110-22-001291:0
1,323 shares0Common StockSEC:0001179110-21-005927:0
1,323 shares0Common StockSEC:0001179110-21-005927
About PARRISH MARK W
Mark W. Parrish serves as a Director at OMNICELL, Inc. and Viatris Inc. He plays a key role in governance and strategy for these companies, bringing his experience in the healthcare sector.